Tuesday, June 23, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 973 of 1,261

  1. US 7884066

    NELL-1 enhanced bone mineralization

    The Regents of the University of California · Granted Feb 8, 2011 · Expires Feb 3, 2031

    granted

  2. US 7884119

    Triazole derivatives useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Feb 8, 2011 · Expires Feb 3, 2031

    granted

  3. US 7884111

    2,4-pyrimidinediamine compounds and uses as anti-proliferative agents

    Rigel Pharmaceuticals, Inc. · Granted Feb 8, 2011 · Expires Feb 3, 2031

    granted

  4. US 7883892

    Swine multipotent adult progenitor cells

    Regents of the University of Minnesota · Granted Feb 8, 2011 · Expires Feb 3, 2031

    granted

  5. US 7884091

    Methods for treating delirium using glucocorticoid receptor-specific antagonists

    Corcept Therapeutics Incorporated · Granted Feb 8, 2011 · Expires Feb 3, 2031

    granted

  6. US 7884211

    Dimeric small molecule potentiators of apoptosis

    The Board of Regents of the University of Texas System · Granted Feb 8, 2011 · Expires Feb 3, 2031

    granted

  7. US 7884178

    Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of use

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 8, 2011 · Expires Feb 3, 2031

    granted

  8. US 7884199

    HCV NS3-NS4 protease resistance mutants

    Vertex Pharmaceuticals Incorporated · Granted Feb 8, 2011 · Expires Feb 3, 2031

    granted

  9. US 7883710

    Peptide vaccines against Group A streptococci

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 8, 2011 · Expires Feb 3, 2031

    granted

  10. US 7884234

    N-phenyloxamide derivatives

    Institute of Medicinal Molecular Design, Inc. · Granted Feb 8, 2011 · Expires Feb 3, 2031

    granted

  11. US 7884208

    Crystals of laquinimod sodium, and process for the manufacture thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Feb 8, 2011 · Expires Feb 3, 2031

    granted

  12. US 7883881

    Inhibitors of GSK-3 and crystal structures of GSK-3β protein and protein complexes

    Vertex Pharmaceuticals Incorporated · Granted Feb 8, 2011 · Expires Feb 3, 2031

    granted

  13. US 7884226

    Purification of rosuvatatin intermediate by thin film evaporation and chemical method

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Feb 8, 2011 · Expires Feb 3, 2031

    granted

  14. US 7879370

    Composition of which chief ingredient is polysaccharides having an immunoregulatory function

    American Regent, Inc. · Granted Feb 1, 2011 · Expires Jan 27, 2031

    granted

  15. US 7879324

    Fusion molecules and methods for treatment of immune diseases

    The Regents of the University of California · Granted Feb 1, 2011 · Expires Jan 27, 2031

    granted

  16. US 7879334

    Fusion molecules and treatment of IgE-mediated allergic diseases

    The Regents of the University of California · Granted Feb 1, 2011 · Expires Jan 27, 2031

    granted

  17. US 7879576

    Marine actinomycete taxon for drug and fermentation product discovery

    The Regents of the University of California · Granted Feb 1, 2011 · Expires Jan 27, 2031

    granted

  18. US 7879874

    Quinuclidine derivatives and medicinal compositions containing the same

    Almirall, S.A. · Granted Feb 1, 2011 · Expires Jan 27, 2031

    granted

  19. US 7879856

    Diaminothiazoles useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Feb 1, 2011 · Expires Jan 27, 2031

    granted

  20. US 7880007

    Bicyclic substituted phenyl piperidine modulators of muscarinic receptors

    Vertex Pharmaceuticals Incorporated · Granted Feb 1, 2011 · Expires Jan 27, 2031

    granted

  21. US 7879909

    Use of Treprostinil to treat neuropathic diabetic foot ulcers

    United Therapeutics Corporation · Granted Feb 1, 2011 · Expires Jan 27, 2031

    granted

  22. US 7880008

    Heterocycles useful as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Feb 1, 2011 · Expires Jan 27, 2031

    granted

  23. US 7879834

    Spiroindoline modulators of muscarinic receptors

    Vertex Pharmaceuticals Incorporated · Granted Feb 1, 2011 · Expires Jan 27, 2031

    granted

  24. US 7880010

    Crystalline forms of a dimethylphenyl compound

    Theravance, Inc. · Granted Feb 1, 2011 · Expires Jan 27, 2031

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.